{
  "url": "https://finance.yahoo.com/news/cheniere-energy-second-quarter-2025-182941728.html",
  "authorsByline": "Simply Wall St",
  "articleId": "a72d143713d2413ba0029e6a4c9754f9",
  "source": {
    "domain": "finance.yahoo.com",
    "location": {
      "country": "us",
      "state": "CA",
      "county": "Santa Clara County",
      "city": "Sunnyvale",
      "coordinates": {
        "lat": 37.3688301,
        "lon": -122.036349
      }
    }
  },
  "imageUrl": "https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c",
  "country": "us",
  "language": "en",
  "pubDate": "2025-08-12T18:29:41+00:00",
  "addDate": "2025-08-12T18:41:40.109590+00:00",
  "refreshDate": "2025-08-12T18:41:40.109592+00:00",
  "score": 1.0,
  "title": "Cheniere Energy Second Quarter 2025 Earnings: Beats Expectations",
  "description": "NYSE:LNG 1 Year Share Price vs Fair Value Explore Cheniere Energy's Fair Values from the Community and select yours...",
  "content": "Explore Cheniere Energy's Fair Values from the Community and select yours\n\u2022 Profit margin: 35% (up from 28% in 2Q 2024). The increase in margin was driven by higher revenue.\n\u2022 EPS: US$7.32 (up from US$3.85 in 2Q 2024).\n\nAI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.\n\nAll figures shown in the chart above are for the trailing 12 month (TTM) period\n\nRevenue exceeded analyst estimates by 8.1%. Earnings per share (EPS) also surpassed analyst estimates by 191%.\n\nLooking ahead, revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Oil and Gas industry in the US.\n\nPerformance of the American Oil and Gas industry.\n\nThe company's shares are down 4.9% from a week ago.\n\nWe should say that we've discovered 3 warning signs for Cheniere Energy (1 doesn't sit too well with us!) that you should be aware of before investing here.\n\nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.\n\n\n\nThis article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.",
  "medium": "Article",
  "links": [
    "https://simplywall.st/markets/us/energy/oil-gas?blueprint=3983751&utm_medium=finance_user&utm_campaign=industry&utm_source=yahoo",
    "https://simplywall.st/company/id/DC4D0CF4-6274-4C87-B3A5-09937C924705/future?blueprint=3983751&amp;utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo",
    "https://simplywall.st/stock/nyse/lng?blueprint=3983751&utm_medium=finance_user&utm_campaign=narratives-news-header&utm_source=yahoo&utm_content=narrative-header-stocks-page",
    "https://au.finance.yahoo.com/quote/LNG",
    "https://simplywall.st/company/id/DC4D0CF4-6274-4C87-B3A5-09937C924705?blueprint=3983751&utm_medium=finance_user&utm_campaign=conclusion&utm_source=yahoo",
    "https://simplywall.st/discover/investing-ideas/434426/us-transformative-artificial-intelligence-ai-healthcare-stocks/global?blueprint=3983751&utm_medium=finance_user&utm_campaign=investing-ideas&utm_source=yahoo&utm_content=ai-healthcare"
  ],
  "labels": [
    {
      "name": "Roundup"
    }
  ],
  "claim": "",
  "verdict": "",
  "keywords": [
    {
      "name": "Cheniere Energy",
      "weight": 0.089835964
    },
    {
      "name": "analyst forecasts",
      "weight": 0.0830701
    },
    {
      "name": "Simply Wall St",
      "weight": 0.077985965
    },
    {
      "name": "analyst estimates",
      "weight": 0.07687676
    },
    {
      "name": "higher revenue",
      "weight": 0.0679915
    },
    {
      "name": "historical data",
      "weight": 0.06480443
    },
    {
      "name": "Cheniere Energy Second Quarter 2025 Earnings",
      "weight": 0.06272517
    },
    {
      "name": "Revenue",
      "weight": 0.061574306
    },
    {
      "name": "revenue",
      "weight": 0.061574306
    },
    {
      "name": "fundamental data",
      "weight": 0.060853347
    }
  ],
  "topics": [
    {
      "name": "Markets"
    }
  ],
  "categories": [
    {
      "name": "Finance"
    }
  ],
  "taxonomies": [
    {
      "name": "/News/Business News/Financial Markets News",
      "score": 0.9677734375
    },
    {
      "name": "/News/Business News/Company News",
      "score": 0.955078125
    },
    {
      "name": "/Finance/Investing/Stocks & Bonds",
      "score": 0.90771484375
    },
    {
      "name": "/Business & Industrial/Energy & Utilities/Oil & Gas",
      "score": 0.73681640625
    }
  ],
  "sentiment": {
    "positive": 0.11154445,
    "negative": 0.4904779,
    "neutral": 0.39797765
  },
  "summary": "Cheniere Energy's Q2 2025 earnings exceeded analyst estimates by 8.1% and earnings per share (EPS) also exceeded forecasts by 191%. The company's profit margin was increased by 35%, driven by higher revenue. Looking ahead, revenue is expected to grow 7.4% p.",
  "shortSummary": "Cheniere Energy's Q4 earnings surpassed expectations, driven by higher revenue, but warn of potential price increases and market closures.",
  "translation": "",
  "translatedTitle": "",
  "translatedDescription": "",
  "translatedSummary": "",
  "reprint": true,
  "reprintGroupId": "356078ed17f34df38f43b536fce11888",
  "places": [],
  "scraped_sources": [
    {
      "url": "https://simplywall.st/company/id/DC4D0CF4-6274-4C87-B3A5-09937C924705?blueprint=3983751&utm_medium=finance_user&utm_campaign=conclusion&utm_source=yahoo",
      "text": "Cheniere Energy (LNG) Stock Overview\nAn energy infrastructure company, primarily engages in the liquefied natural gas (LNG) related businesses in the United States. More details\n| Snowflake Score | |\n|---|---|\n| Valuation | 4/6 |\n| Future Growth | 1/6 |\n| Past Performance | 2/6 |\n| Financial Health | 3/6 |\n| Dividends | 2/6 |\nLNG Community Fair Values\nSee what 73 others think this stock is worth. Follow their fair value or set your own to get alerts.\nCheniere Energy, Inc. Competitors\nPrice History & Performance\n| Historical stock prices | |\n|---|---|\n| Current Share Price | US$230.05 |\n| 52 Week High | US$257.65 |\n| 52 Week Low | US$175.14 |\n| Beta | 0.43 |\n| 1 Month Change | -2.20% |\n| 3 Month Change | -1.15% |\n| 1 Year Change | 25.54% |\n| 3 Year Change | 46.00% |\n| 5 Year Change | 326.26% |\n| Change since IPO | 5,224.97% |\nRecent News & Updates\nThese 4 Measures Indicate That Cheniere Energy (NYSE:LNG) Is Using Debt Extensively\nJul 21Cheniere Energy: Still A Buy Despite The Soar And Solid Long-Term LNG Play\nJul 09Cheniere Energy, Inc.'s (NYSE:LNG) Business Is Trailing The Market But Its Shares Aren't\nJul 03Recent updates\nThese 4 Measures Indicate That Cheniere Energy (NYSE:LNG) Is Using Debt Extensively\nJul 21Cheniere Energy: Still A Buy Despite The Soar And Solid Long-Term LNG Play\nJul 09Cheniere Energy, Inc.'s (NYSE:LNG) Business Is Trailing The Market But Its Shares Aren't\nJul 03Increases to CEO Compensation Might Be Put On Hold For Now at Cheniere Energy, Inc. (NYSE:LNG)\nMay 08Cheniere Energy's LNG Benefits From A U.S. Trade Deficit\nApr 23Is Cheniere Energy (NYSE:LNG) Using Too Much Debt?\nApr 19Returns On Capital Are Showing Encouraging Signs At Cheniere Energy (NYSE:LNG)\nApr 02Cheniere Energy: LNG Demand To Double, Why This Market Leader Is A Buy\nMar 19Cheniere Energy: Valuation Extended, But U.S. LNG Dominance May Rise In Trade Conflict\nFeb 21Cheniere Energy: The Only Pure LNG Player Worth It\nFeb 14Cheniere Energy: A Strong Choice For Serious Investors\nJan 06Benign Growth For Cheniere Energy, Inc. (NYSE:LNG) Underpins Its Share Price\nDec 27Is Cheniere Energy (NYSE:LNG) A Risky Investment?\nDec 09There's Been No Shortage Of Growth Recently For Cheniere Energy's (NYSE:LNG) Returns On Capital\nNov 21Cheniere Energy Remains A Strong Buy Wide-Moat Powerhouse\nNov 03Cheniere Energy, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next\nNov 03Cheniere Energy (NYSE:LNG) Will Pay A Larger Dividend Than Last Year At $0.50\nNov 01Cheniere Energy: Strong Returns Through Expansion And Capital Returns\nSep 29Cheniere Energy, Inc.'s (NYSE:LNG) Earnings Are Not Doing Enough For Some Investors\nSep 27Cheniere Energy, Inc.: A Strong Company With Great Prospects\nSep 18Is Cheniere Energy (NYSE:LNG) A Risky Investment?\nSep 06Cheniere Energy: Long-Term Contracts, Global Demand, Rising Returns\nAug 19Strengthening Market Footprint With Calculated Partnerships And Operational Excellence Boosts Long-Term Prospects\nExpansion projects and regulatory progress illustrate potential for production capacity growth and long-term revenue and net margin increase.Cheniere Energy (NYSE:LNG) Is Very Good At Capital Allocation\nAug 16Cheniere Energy: A Wide-Moat LNG Fortress With Accelerating Dividend Growth\nAug 11Cheniere Energy: Buybacks And Attractive Valuation To Propel The Share Price\nJun 11Cheniere Energy Is About To Become A Wide-Moat Dividend Growth Powerhouse\nMay 08Cheniere Energy: Expect The Same In Q1 Earnings, Growth Story Still Intact\nApr 29Cheniere Energy: Sales Up But Prices Down, Leading To Hold\nMar 24Cheniere Energy - Not Even Qatar Can Derail This Bull Case\nMar 06Cheniere Energy Is Transforming Into A Stable Dividend Growth Stock\nFeb 13Shareholder Returns\n| LNG | US Oil and Gas | US Market | |\n|---|---|---|---|\n| 7D | -4.9% | -1.9% | 0.7% |\n| 1Y | 25.5% | -3.3% | 19.4% |\nReturn vs Industry: LNG exceeded the US Oil and Gas industry which returned -3.3% over the past year.\nReturn vs Market: LNG exceeded the US Market which returned 19.4% over the past year.\nPrice Volatility\n| LNG volatility | |\n|---|---|\n| LNG Average Weekly Movement | 4.4% |\n| Oil and Gas Industry Average Movement | 5.4% |\n| Market Average Movement | 6.5% |\n| 10% most volatile stocks in US Market | 17.7% |\n| 10% least volatile stocks in US Market | 3.1% |\nStable Share Price: LNG has not had significant price volatility in the past 3 months compared to the US market.\nVolatility Over Time: LNG's weekly volatility (4%) has been stable over the past year.\nAbout the Company\n| Founded | Employees | CEO | Website |\n|---|---|---|---|\n| 1983 | 1,714 | Jack Fusco | www.cheniere.com |\nCheniere Energy, Inc., an energy infrastructure company, primarily engages in the liquefied natural gas (LNG) related businesses in the United States. The company owns and operates the Sabine Pass LNG terminal in Cameron Parish, Louisiana; and the Corpus Christi LNG terminal near Corpus Christi, Texas. It also owns and operates the Creole Trail pipeline, a 94-mile natural gas supply pipeline that interconnects the Sabine Pass LNG Terminal with several interstate and intrastate pipelines; and the Corpus Christi pipeline, a 21-mile natural gas supply pipeline that interconnects the Corpus Christi LNG terminal with interstate and intrastate natural gas pipelines.\nCheniere Energy, Inc. Fundamentals Summary\n| LNG fundamental statistics | |\n|---|---|\n| Market cap | US$50.73b |\n| Earnings (TTM) | US$3.84b |\n| Revenue (TTM) | US$18.23b |\nIs LNG overvalued?\nSee Fair Value and valuation analysisEarnings & Revenue\n| LNG income statement (TTM) | |\n|---|---|\n| Revenue | US$18.23b |\n| Cost of Revenue | US$9.66b |\n| Gross Profit | US$8.57b |\n| Other Expenses | US$4.72b |\n| Earnings | US$3.84b |\nLast Reported Earnings\nJun 30, 2025\nNext Earnings Date\nn/a\n| Earnings per share (EPS) | 17.49 |\n| Gross Margin | 46.99% |\n| Net Profit Margin | 21.09% |\n| Debt/Equity Ratio | 200.0% |\nHow did LNG perform over the long term?\nSee historical performance and comparisonDividends\nDoes LNG pay a reliable dividends?\nSee LNG dividend history and benchmarks| Cheniere Energy dividend dates | |\n|---|---|\n| Ex Dividend Date | Aug 08 2025 |\n| Dividend Pay Date | Aug 18 2025 |\n| Days until Ex dividend | 5 days |\n| Days until Dividend pay date | 5 days |\nDoes LNG pay a reliable dividends?\nSee LNG dividend history and benchmarksCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/11 11:21 |\n| End of Day Share Price | 2025/08/11 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nCheniere Energy, Inc. is covered by 50 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Ishan Majumdar | Baptista Research |\n| Kannan Venkateshwar | Barclays |\n| Theresa Chen | Barclays |"
    },
    {
      "url": "https://simplywall.st/markets/us/energy/oil-gas?blueprint=3983751&utm_medium=finance_user&utm_campaign=industry&utm_source=yahoo",
      "text": "Over the last 7 days, the Oil and Gas industry has dropped 1.9%, driven by pullbacks in Venture Global and Exxon Mobil of 19% and 1.4%, respectively. The industry has fallen 3.3% in the last year. Looking forward, earnings are forecast to grow by 13% annually.\nHas the U.S. Oil and Gas Industry valuation changed over the past few years?\n| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |\n|---|---|---|---|---|---|---|\n| Tue, 12 Aug 2025 | US$2.0t | US$1.7t | US$116.0b | 13x | 17.6x | 1.2x |\n| Thu, 10 Jul 2025 | US$2.1t | US$1.7t | US$122.4b | 12.5x | 17.5x | 1.2x |\n| Sat, 07 Jun 2025 | US$2.0t | US$1.7t | US$122.2b | 12.1x | 16.3x | 1.1x |\n| Mon, 05 May 2025 | US$2.0t | US$1.7t | US$123.4b | 11.7x | 16x | 1.1x |\n| Wed, 02 Apr 2025 | US$2.2t | US$1.7t | US$130.4b | 12.8x | 17.1x | 1.3x |\n| Fri, 28 Feb 2025 | US$2.1t | US$1.7t | US$131.8b | 12.3x | 16.2x | 1.2x |\n| Sun, 26 Jan 2025 | US$2.2t | US$1.8t | US$145.7b | 12x | 15.3x | 1.3x |\n| Tue, 24 Dec 2024 | US$2.0t | US$1.8t | US$144.8b | 11.2x | 13.9x | 1.1x |\n| Thu, 21 Nov 2024 | US$2.2t | US$1.8t | US$146.4b | 11.7x | 15.3x | 1.3x |\n| Sat, 19 Oct 2024 | US$2.1t | US$1.8t | US$161.1b | 10.7x | 13.3x | 1.2x |\n| Mon, 16 Sep 2024 | US$2.0t | US$1.8t | US$157.8b | 9.9x | 12.7x | 1.1x |\n| Wed, 14 Aug 2024 | US$2.1t | US$1.8t | US$157.9b | 10.2x | 13.2x | 1.2x |\n| Fri, 12 Jul 2024 | US$2.0t | US$1.8t | US$162.2b | 11x | 12.5x | 1.1x |\n| Sun, 09 Jun 2024 | US$2.0t | US$1.8t | US$162.4b | 10.8x | 12.5x | 1.1x |\n| Tue, 07 May 2024 | US$2.1t | US$1.8t | US$163.9b | 9.9x | 12.8x | 1.2x |\n| Thu, 04 Apr 2024 | US$2.2t | US$1.8t | US$192.5b | 10x | 11.6x | 1.2x |\n| Sat, 02 Mar 2024 | US$2.0t | US$1.8t | US$194.9b | 8.1x | 10.2x | 1.1x |\n| Mon, 29 Jan 2024 | US$2.0t | US$1.9t | US$227.5b | 7.9x | 8.9x | 1.1x |\n| Wed, 27 Dec 2023 | US$2.0t | US$1.9t | US$230.1b | 7.8x | 8.9x | 1.1x |\n| Fri, 24 Nov 2023 | US$2.0t | US$1.9t | US$230.4b | 8x | 8.8x | 1.1x |\n| Sun, 22 Oct 2023 | US$2.1t | US$2.0t | US$261.5b | 6.5x | 8.2x | 1.1x |\n| Tue, 19 Sep 2023 | US$2.2t | US$2.0t | US$261.4b | 6.7x | 8.3x | 1.1x |\n| Thu, 17 Aug 2023 | US$2.0t | US$2.0t | US$261.3b | 6.6x | 7.8x | 1x |\n| Sat, 15 Jul 2023 | US$1.9t | US$2.2t | US$307.3b | 5.6x | 6.3x | 0.9x |\n| Mon, 12 Jun 2023 | US$1.9t | US$2.2t | US$307.3b | 5.4x | 6.3x | 0.9x |\n| Wed, 10 May 2023 | US$1.9t | US$2.2t | US$310.4b | 5.2x | 6.2x | 0.9x |\n| Fri, 07 Apr 2023 | US$2.0t | US$2.2t | US$275.3b | 6x | 7.3x | 0.9x |\n| Sun, 05 Mar 2023 | US$2.1t | US$2.2t | US$275.5b | 6.6x | 7.4x | 0.9x |\n| Tue, 31 Jan 2023 | US$2.1t | US$2.2t | US$258.8b | 7x | 8.2x | 1x |\n| Thu, 29 Dec 2022 | US$2.0t | US$2.2t | US$254.2b | 6.8x | 8x | 1x |\n| Sat, 26 Nov 2022 | US$2.2t | US$2.1t | US$253.9b | 7.5x | 8.7x | 1x |\n| Mon, 24 Oct 2022 | US$2.1t | US$1.9t | US$190.1b | 9.8x | 11.1x | 1.1x |\n| Wed, 21 Sep 2022 | US$1.9t | US$1.9t | US$190.1b | 9.1x | 10.2x | 1x |\n| Fri, 19 Aug 2022 | US$2.0t | US$1.9t | US$189.8b | 10.1x | 10.4x | 1x |\n10.4x\nWhich industries have driven the changes within the U.S. Energy industry?\n| US Market | 0.73% | |\n| Energy | -1.90% | |\n| Oil and Gas | -1.93% | |\n| Coal and Fuels | 0.73% | |\n| Integrated Oil and Gas | -0.10% | |\n| Oil and Gas Exploration and Production | -2.71% | |\n| Oil and Gas Refining and Marketing | -3.47% | |\n| Oil and Gas Storage and Transportation | -3.48% |\nWhich companies have driven the market over the last 7 days?\n| Company | Last Price | 7D | 1Y | Valuation | |\n|---|---|---|---|---|---|\n| CVX Chevron | US$153.45 | 1.6% +US$47.6b | 5.8% | PE22.7x | |\n| OXY Occidental Petroleum | US$43.71 | 2.0% +US$849.9m | -25.9% | PE24.9x | |\n| APA APA | US$19.92 | 7.2% +US$419.0m | -31.1% | PE6.6x | |\n| LEU Centrus Energy | US$219.10 | 4.3% +US$410.7m | 459.4% | PE38.1x | |\n| DVN Devon Energy | US$32.87 | 2.9% +US$357.2m | -27.5% | PE7.3x |"
    },
    {
      "url": "https://simplywall.st/discover/investing-ideas/434426/us-transformative-artificial-intelligence-ai-healthcare-stocks/global?blueprint=3983751&utm_medium=finance_user&utm_campaign=investing-ideas&utm_source=yahoo&utm_content=ai-healthcare",
      "text": "Results\n25\nArtificial intelligence (AI) is set to transform healthcare by enhancing diagnostics, personalizing medicine, boosting operational efficiency, expanding remote care, and accelerating research. AI outperforms humans in detecting diseases like cancer from scans, tailors treatments using genetic and lifestyle data, and streamlines hospital workflows with tools like predictive analytics and automated transcription. It powers telemedicine, monitors chronic conditions in real-time, and speeds up drug discovery by analyzing vast datasets for insights into complex diseases. Despite challenges like data privacy, bias, and integration costs, AI\u2019s ability to improve accuracy, access, and affordability could save billions and extend lives, marking a seismic shift in healthcare delivery and outcomes.\n25 companies\nCaris Life Sciences\nMarket Cap: US$8.4b\nAn artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.\nCAI\nUS$30.21\n7D\n-0.3%\n1Y\nn/a\nRakovina Therapeutics\nMarket Cap: US$11.4m\nA biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.\nRKVT.F\nUS$0.42\n7D\n19.3%\n1Y\nn/a\nCosmo Pharmaceuticals\nMarket Cap: US$889.4m\nFocuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.\nCMOP.F\nUS$75.00\n7D\n0%\n1Y\n-8.5%\nGubra\nMarket Cap: US$5.8b\nA biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.\nGUBR.F\nUS$60.15\n7D\n0%\n1Y\nn/a\nEvaxion\nMarket Cap: US$17.9m\nA clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.\nEVAX\nUS$2.77\n7D\n1.8%\n1Y\n-77.8%\nImmunoPrecise Antibodies\nMarket Cap: US$92.3m\nOperates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company.\nIPA\nUS$1.90\n7D\n3.8%\n1Y\n219.9%\nEvolent Health\nMarket Cap: US$1.0b\nThrough its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.\nEVH\nUS$9.22\n7D\n-5.6%\n1Y\n-63.5%\nGeneDx Holdings\nMarket Cap: US$3.2b\nA genomics company, provides genetic testing services.\nWGS\nUS$110.54\n7D\n3.6%\n1Y\n223.7%\nWELL Health Technologies\nMarket Cap: US$1.2b\nOperates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.\nWHTC.F\nUS$3.51\n7D\n7.7%\n1Y\n5.7%\nRevenio Group Oyj\nMarket Cap: US$650.5m\nProvides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally.\nREVX.F\nUS$31.47\n7D\n0%\n1Y\nn/a\nRadNet\nMarket Cap: US$4.1b\nProvides outpatient diagnostic imaging services in the United States and internationally.\nRDNT\nUS$62.00\n7D\n11.2%\n1Y\n0.6%\nCareCloud\nMarket Cap: US$113.2m\nA healthcare information technology (IT) company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States.\nCCLD\nUS$2.56\n7D\n7.6%\n1Y\n25.5%\nSimulations Plus\nMarket Cap: US$285.2m\nDevelops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.\nSLP\nUS$13.87\n7D\n6.8%\n1Y\n-61.8%\nBioXcel Therapeutics\nMarket Cap: US$24.5m\nTogether with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.\nBTAI\nUS$6.40\n7D\n152.0%\n1Y\n-39.2%\nPerimeter Medical Imaging AI\nMarket Cap: US$32.9m\nA medical technology company, provides advanced imaging solutions to address unmet medical needs.\nPYNK.F\nUS$0.19\n7D\n-1.3%\n1Y\n-41.4%\nNano-X Imaging\nMarket Cap: US$296.8m\nDevelops a commercial-grade tomographic imaging device with a digital X-ray source.\nNNOX\nUS$4.71\n7D\n-0.8%\n1Y\n-30.0%\nCeriBell\nMarket Cap: US$473.3m\nOperates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.\nCBLL\nUS$12.12\n7D\n-20.4%\n1Y\nn/a\nGuardant Health\nMarket Cap: US$6.8b\nA precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.\nGH\nUS$54.80\n7D\n24.0%\n1Y\n79.8%\nOmniAb\nMarket Cap: US$241.7m\nA biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.\nOABI\nUS$1.96\n7D\n0.5%\n1Y\n-52.5%\nNeuroOne Medical Technologies\nMarket Cap: US$37.3m\nA medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.\nNMTC\nUS$0.74\n7D\n-10.3%\n1Y\n-1.6%\nXtalPi Holdings\nMarket Cap: US$29.9b\nAn investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.\nQNTP.F\nUS$0.77\n7D\n12.9%\n1Y\nn/a\nAbsci\nMarket Cap: US$409.6m\nOperates as a data-first generative artificial intelligence (AI) drug creation company in the United States.\nABSI\nUS$2.85\n7D\n-4.7%\n1Y\n-22.1%\nHealwell AI\nMarket Cap: US$392.1m\nA healthcare artificial intelligence company, develops and commercializes clinical decision support systems in Canada, New Zealand, Australia, and the United Kingdom.\nHWAI.F\nUS$1.03\n7D\n14.4%\n1Y\n-31.3%\nVeradigm\nMarket Cap: US$806.7m\nA healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.\nMDRX\nUS$4.65\n7D\n-4.1%\n1Y\n-51.1%\nPersonalis\nMarket Cap: US$399.9m\nDevelops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.\nPSNL\nUS$4.50\n7D\n-19.2%\n1Y\n4.4%"
    },
    {
      "url": "https://simplywall.st/stock/nyse/lng?blueprint=3983751&utm_medium=finance_user&utm_campaign=narratives-news-header&utm_source=yahoo&utm_content=narrative-header-stocks-page",
      "text": "Cheniere Energy, Inc., an energy infrastructure company, primarily engages in the liquefied natural gas (LNG) related businesses in the United States. The company owns and operates the Sabine Pass LNG terminal in Cameron Parish, Louisiana; and the Corpus Christi LNG terminal near Corpus Christi, Texas. It also owns and operates the Creole Trail pipeline, a 94-mile natural gas supply pipeline that interconnects the Sabine Pass LNG Terminal with several interstate and intrastate pipelines; and the Corpus Christi pipeline, a 21-mile natural gas supply pipeline that interconnects the Corpus Christi LNG terminal with interstate and intrastate natural gas pipelines. In addition, the company engages in the LNG and natural gas marketing business. Cheniere Energy, Inc. was incorporated in 1983 and is headquartered in Houston, Texas.\nU.S. Market Performance\n7D7 Days: 0.7%\n3M3 Months: 7.8%\n1Y1 Year: 19.4%\nYTDYear to Date: 8.1%\nThe market has stayed flat over the 7 days. As for the longer term, the market has risen 19% in the past 12 months. Looking forward, earnings are forecast to grow by 15% annually. Market details \u203a\nThis week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond."
    },
    {
      "url": "https://simplywall.st/company/id/DC4D0CF4-6274-4C87-B3A5-09937C924705/future?blueprint=3983751&amp;utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo",
      "text": "Cheniere Energy Future Growth\nFuture criteria checks 1/6\nCheniere Energy's earnings are forecast to decline at 6.1% per annum while its annual revenue is expected to grow at 7.4% per year. EPS is expected to decline by 3.3% per annum. Return on equity is forecast to be 34.3% in 3 years.\nKey information\n-6.1%\nEarnings growth rate\n-3.33%\nEPS growth rate\n| Oil and Gas earnings growth | 13.0% |\n| Revenue growth rate | 7.4% |\n| Future return on equity | 34.26% |\n| Analyst coverage | Good |\n| Last updated | 08 Aug 2025 |\nRecent future growth updates\nRecent updates\nThese 4 Measures Indicate That Cheniere Energy (NYSE:LNG) Is Using Debt Extensively\nJul 21Cheniere Energy: Still A Buy Despite The Soar And Solid Long-Term LNG Play\nJul 09Cheniere Energy, Inc.'s (NYSE:LNG) Business Is Trailing The Market But Its Shares Aren't\nJul 03Increases to CEO Compensation Might Be Put On Hold For Now at Cheniere Energy, Inc. (NYSE:LNG)\nMay 08Cheniere Energy's LNG Benefits From A U.S. Trade Deficit\nApr 23Is Cheniere Energy (NYSE:LNG) Using Too Much Debt?\nApr 19Returns On Capital Are Showing Encouraging Signs At Cheniere Energy (NYSE:LNG)\nApr 02Cheniere Energy: LNG Demand To Double, Why This Market Leader Is A Buy\nMar 19Cheniere Energy: Valuation Extended, But U.S. LNG Dominance May Rise In Trade Conflict\nFeb 21Cheniere Energy: The Only Pure LNG Player Worth It\nFeb 14Cheniere Energy: A Strong Choice For Serious Investors\nJan 06Benign Growth For Cheniere Energy, Inc. (NYSE:LNG) Underpins Its Share Price\nDec 27Is Cheniere Energy (NYSE:LNG) A Risky Investment?\nDec 09There's Been No Shortage Of Growth Recently For Cheniere Energy's (NYSE:LNG) Returns On Capital\nNov 21Cheniere Energy Remains A Strong Buy Wide-Moat Powerhouse\nNov 03Cheniere Energy, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next\nNov 03Cheniere Energy (NYSE:LNG) Will Pay A Larger Dividend Than Last Year At $0.50\nNov 01Cheniere Energy: Strong Returns Through Expansion And Capital Returns\nSep 29Cheniere Energy, Inc.'s (NYSE:LNG) Earnings Are Not Doing Enough For Some Investors\nSep 27Cheniere Energy, Inc.: A Strong Company With Great Prospects\nSep 18Is Cheniere Energy (NYSE:LNG) A Risky Investment?\nSep 06Cheniere Energy: Long-Term Contracts, Global Demand, Rising Returns\nAug 19Strengthening Market Footprint With Calculated Partnerships And Operational Excellence Boosts Long-Term Prospects\nExpansion projects and regulatory progress illustrate potential for production capacity growth and long-term revenue and net margin increase.Cheniere Energy (NYSE:LNG) Is Very Good At Capital Allocation\nAug 16Cheniere Energy: A Wide-Moat LNG Fortress With Accelerating Dividend Growth\nAug 11Cheniere Energy: Buybacks And Attractive Valuation To Propel The Share Price\nJun 11Cheniere Energy Is About To Become A Wide-Moat Dividend Growth Powerhouse\nMay 08Cheniere Energy: Expect The Same In Q1 Earnings, Growth Story Still Intact\nApr 29Cheniere Energy: Sales Up But Prices Down, Leading To Hold\nMar 24Cheniere Energy - Not Even Qatar Can Derail This Bull Case\nMar 06Cheniere Energy Is Transforming Into A Stable Dividend Growth Stock\nFeb 13Earnings and Revenue Growth Forecasts\n| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |\n|---|---|---|---|---|---|\n| 12/31/2027 | 23,283 | 2,915 | 3,385 | 6,386 | 9 |\n| 12/31/2026 | 23,699 | 2,997 | 3,147 | 5,633 | 13 |\n| 12/31/2025 | 20,921 | 2,921 | 2,393 | 5,372 | 8 |\n| 6/30/2025 | 18,231 | 3,844 | 2,359 | 5,091 | N/A |\n| 3/31/2025 | 16,739 | 3,101 | 3,165 | 5,376 | N/A |\n| 12/31/2024 | 15,454 | 3,252 | 3,156 | 5,394 | N/A |\n| 9/30/2024 | 15,579 | 3,652 | 3,113 | 5,473 | N/A |\n| 6/30/2024 | 15,934 | 4,460 | 3,550 | 5,780 | N/A |\n| 3/31/2024 | 16,763 | 4,949 | 4,184 | 6,243 | N/A |\n| 12/31/2023 | 19,781 | 9,881 | 6,297 | 8,418 | N/A |\n| 9/30/2023 | 24,373 | 12,441 | 7,729 | 9,650 | N/A |\n| 6/30/2023 | 29,086 | 8,355 | 8,500 | 10,351 | N/A |\n| 3/31/2023 | 33,054 | 7,727 | 8,925 | 11,289 | N/A |\n| 12/31/2022 | 33,306 | 1,428 | 8,693 | 10,523 | N/A |\n| 9/30/2022 | 32,382 | -3,832 | 6,439 | 7,983 | N/A |\n| 6/30/2022 | 26,813 | -2,531 | 4,719 | 6,268 | N/A |\n| 3/31/2022 | 21,871 | -3,601 | 3,104 | 4,058 | N/A |\n| 12/31/2021 | 17,531 | -2,343 | 1,503 | 2,469 | N/A |\n| 9/30/2021 | 12,235 | -1,214 | 1,394 | 2,557 | N/A |\n| 6/30/2021 | 10,467 | -593 | 314 | 1,610 | N/A |\n| 3/31/2021 | 9,865 | -67 | 284 | 1,757 | N/A |\n| 12/31/2020 | 9,293 | -85 | -574 | 1,265 | N/A |\n| 9/30/2020 | 9,101 | 1,048 | -400 | 1,506 | N/A |\n| 6/30/2020 | 9,757 | 1,193 | -430 | 2,101 | N/A |\n| 3/31/2020 | 9,462 | 882 | -992 | 1,995 | N/A |\n| 12/31/2019 | 9,157 | 648 | -1,223 | 1,833 | N/A |\n| 9/30/2019 | 8,667 | -224 | -1,940 | 1,578 | N/A |\n| 6/30/2019 | 8,466 | 159 | -1,875 | 1,768 | N/A |\n| 3/31/2019 | 7,944 | 255 | N/A | 1,933 | N/A |\n| 12/31/2018 | 7,995 | 471 | N/A | 1,990 | N/A |\n| 9/30/2018 | 7,512 | 531 | N/A | 1,840 | N/A |\n| 6/30/2018 | 7,052 | 177 | N/A | 1,677 | N/A |\n| 3/31/2018 | 6,675 | -90 | N/A | 1,391 | N/A |\n| 12/31/2017 | 5,646 | -393 | N/A | 1,231 | N/A |\n| 9/30/2017 | 4,427 | -410 | N/A | 810 | N/A |\n| 6/30/2017 | 3,468 | -222 | N/A | 427 | N/A |\n| 3/31/2017 | 2,430 | -235 | N/A | 36 | N/A |\n| 12/31/2016 | 1,287 | -610 | N/A | -404 | N/A |\n| 9/30/2016 | 783 | -1,011 | N/A | -527 | N/A |\n| 6/30/2016 | 392 | -1,208 | N/A | -483 | N/A |\n| 3/31/2016 | 268 | -1,028 | N/A | -599 | N/A |\n| 12/31/2015 | 270 | -975 | N/A | -483 | N/A |\n| 9/30/2015 | 270 | -843 | N/A | -358 | N/A |\n| 6/30/2015 | 271 | -634 | N/A | -408 | N/A |\n| 3/31/2015 | 271 | -718 | N/A | -120 | N/A |\n| 12/31/2014 | 269 | -548 | N/A | -263 | N/A |\n| 9/30/2014 | 268 | -525 | N/A | -71 | N/A |\nAnalyst Future Growth Forecasts\nEarnings vs Savings Rate: LNG's earnings are forecast to decline over the next 3 years (-6.1% per year).\nEarnings vs Market: LNG's earnings are forecast to decline over the next 3 years (-6.1% per year).\nHigh Growth Earnings: LNG's earnings are forecast to decline over the next 3 years.\nRevenue vs Market: LNG's revenue (7.4% per year) is forecast to grow slower than the US market (9.3% per year).\nHigh Growth Revenue: LNG's revenue (7.4% per year) is forecast to grow slower than 20% per year.\nEarnings per Share Growth Forecasts\nFuture Return on Equity\nFuture ROE: LNG's Return on Equity is forecast to be high in 3 years time (34.3%)\nDiscover growth companies\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/11 17:59 |\n| End of Day Share Price | 2025/08/11 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nCheniere Energy, Inc. is covered by 50 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Ishan Majumdar | Baptista Research |\n| Kannan Venkateshwar | Barclays |\n| Theresa Chen | Barclays |"
    }
  ],
  "argos_summary": "Cheniere Energy has reported a profit margin increase to 35% and earnings per share (EPS) of $7.32, significantly exceeding analyst expectations. Revenue is forecasted to grow at an average of 7.4% annually over the next three years, outpacing the broader Oil and Gas industry growth forecast of 3.9%. However, the company's shares have recently declined by 4.9%, and there are concerns regarding its extensive use of debt and potential warning signs for investors.",
  "argos_id": "7SNIWV1HH"
}